Fuisz Announces Intention to Divest Key E-Commerce

Miami, FL, Nov. 09, 2015 (GLOBE NEWSWIRE) -- Fuisz LLC today announced its intention to divest certain e-commerce patents addressing e-commerce integration with product suppliers.

These comprise a family of three issued patents, including: US 7,962,367 (the “‘367”): US 8,255,379 and US 8,620,756 (each titled, “Method and apparatus for permitting stage-door access to on-line vendor information”) (the “756”).   The underlying application was filed in March 1999.

Joseph Fuisz, member Fuisz LLC, commented: “ The ‘756 is directed, inter alia, to a product supplier system obtaining information about consumer preferences and product purchase trends from an on-line vendor system.   In an era of increased importance of on-line sales, the system described in the ‘756 is a needed tool for product suppliers.

The ‘367 is directed towards the on-line vendor system itself where the on-line system is dynamically linked to a product supplier database. These brief descriptions are of course qualified with reference to the patents themselves. These patents are subject to certain license obligations.”

Richard Fuisz, member Fuisz LLC, stated: “The prescience of the systems described in these patents together with the subsequent growth of e-commerce make particularly valuable intellectual property. We invite interested parties to make a statement of interest.”

Fuisz LLC is a private technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology and diagnostic applications. Fuisz has extensive experience working with big and specialty pharma, as well as large consumer products companies. Fuisz has its headquarters in Miami. www.fuisz.com

Joseph Fuisz 202 669 5097 jfuisz@fuisz.com